Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Scientific Reports
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. scientific reports
  3. articles
  4. article
Encephalopathy in mechanically ventilated adult patients in the intensive care unit: the role of β-Lactam overdosing
Download PDF
Download PDF
  • Article
  • Open access
  • Published: 24 February 2026

Encephalopathy in mechanically ventilated adult patients in the intensive care unit: the role of β-Lactam overdosing

  • Ségolène Gendreau1,2,3,
  • Brice Benelli1,
  • Guillaume Cintrat1,
  • Etienne Dufranc1,
  • Romain Arrestier1,
  • Pierre Bay1,
  • Louise Chantelot1,
  • Pascale Labedade1,
  • Elsa Moncomble1,
  • Guillaume Carteaux1,2,3,
  • Nicolas de Prost1,2,3,
  • Anne Hulin3,4,
  • Claire Pressiat3,4,
  • Armand Mekontso Dessap1,2,3 na1,
  • Keyvan Razazi1,2,3 na1 &
  • ADEL study group

Scientific Reports , Article number:  (2026) Cite this article

We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.

Subjects

  • Encephalopathy
  • Infection
  • Risk factors

Abstract

Delirium is common in ICU and the neurotoxicity induced by antibiotics could be at least in part responsible for it. This study explored the association between β-Lactam overdosing and persistent coma or delirium in patients under mechanical ventilation. All adult patients admitted in ICU receiving continuous sedation were included. β-Lactam’s concentrations were collected during sedation, and up to 48 h after end of continuous sedation. Antibiotic dosings were performed 24 h after initiation or after changing the dose or every 48 h. Overdosing was defined as β-Lactam concentrations above the target for the most resistant pathogen empirically considered, therefore 8 times its clinical breakpoint (BP) according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST). The primary outcome was encephalopathy, defined as either delirium or persistent coma during the 48 h following sedation removal. 224 mechanically ventilated patients were prospectively included, and 190 patients assessed for primary outcome. 58% of patients presented an encephalopathy (30/111 persistent coma and 81/111 delirium), and had longer ventilation duration, more extubation failure, longer ICU length of stay, and higher mortality. β-Lactam overdosing rate was similar in patients with or without encephalopathy. Factors associated with encephalopathy were age, sedation duration and SOFA score. A subgroup analysis suggested an association of encephalopathy with overdosing when defined as per published neurotoxic thresholds. β-Lactam’s overdosing was not associated with occurrence of encephalopathy. These data highlight the complexity of delayed awakening and may suggest to broadening the identification of neurotoxic thresholds of individual antibiotics in further studies.

Data availability

The dataset used and analysed during the current study are available from the corresponding author on reasonable request.

Abbreviations

BP:

Breakpoint

CAM-ICU:

Confusion assessment method for the ICU

EEG:

Electroencephalogram

EUCAST:

The European Committee on Antimicrobial Susceptibility Testing

HPLC:

High-performance liquid chromatography

ICDSC:

Intensive Care Delirium Screening Checklist

ICU:

Intensive care unit

MIC:

Minimum inhibitory concentration

MRI:

Magnetic resonance imaging

RASS:

Richmond Agitation-Sedation Scale

SOFA:

Sepsis-related organ failure assessment

TDM:

Tomodensitometry

References

  1. Reade, M. C. & Finfer, S. Sedation and delirium in the intensive care unit. N. Engl. J. Med. 370, 444–454 (2014).

    Google Scholar 

  2. Ely, E. W. et al. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA 286, 2703–2710 (2001).

    Google Scholar 

  3. Bergeron, N., Dubois, M. J., Dumont, M., Dial, S. & Skrobik, Y. Intensive Care Delirium Screening Checklist: evaluation of a new screening tool. Intensive Care Med. 27, 859–864 (2001).

    Google Scholar 

  4. Stollings, J. L. et al. Delirium in critical illness: clinical manifestations, outcomes, and management. Intensive Care Med. 47, 1089–1103 (2021).

    Google Scholar 

  5. Shehabi, Y. et al. Delirium duration and mortality in lightly sedated, mechanically ventilated intensive care patients*. Crit. Care Med. 38, 2311 (2010).

    Google Scholar 

  6. Ely, E. et al. The impact of delirium in the intensive care unit on hospital length of stay. Intensive Care Med. 27, (2001).

  7. Salluh, J. I. F. et al. Outcome of delirium in critically ill patients: systematic review and meta-analysis. BMJ 350, h2538 (2015).

    Google Scholar 

  8. Pandharipande, P. P. et al. The intensive care delirium research agenda: a multinational, interprofessional perspective. Intensive Care Med. 43, 1329–1339 (2017).

    Google Scholar 

  9. Grahl, J. J. et al. Antimicrobial exposure and the risk of delirium in critically ill patients. Crit. Care Lond. Engl. 22, 337 (2018).

    Google Scholar 

  10. Zaal, I. J., Devlin, J. W., Peelen, L. M. & Slooter, A. J. C. A systematic review of risk factors for delirium in the ICU. Crit. Care Med. 43, 40–47 (2015).

    Google Scholar 

  11. Rey, A., Rossetti, A. O., Miroz, J.-P., Eckert, P. & Oddo, M. Late awakening in survivors of postanoxic coma: early neurophysiologic predictors and association with ICU and long-term neurologic recovery. Crit. Care Med. 47, 85–92 (2019).

    Google Scholar 

  12. Neuville, M. et al. Systematic overdosing of oxa- and cloxacillin in severe infections treated in ICU: risk factors and side effects. Ann. Intensive Care 7, 34 (2017).

    Google Scholar 

  13. Chow, K. M., Hui, A. C. & Szeto, C. C. Neurotoxicity induced by beta-lactam antibiotics: from bench to bedside. Eur. J. Clin. Microbiol. Infect. Dis. Off. Publ. Eur. Soc. Clin. Microbiol. 24, 649–653 (2005).

    Google Scholar 

  14. Imani, S., Buscher, H., Marriott, D., Gentili, S. & Sandaradura, I. Too much of a good thing: a retrospective study of β-lactam concentration-toxicity relationships. J. Antimicrob. Chemother. 72, 2891–2897 (2017).

    Google Scholar 

  15. Bitterman, R., Hussein, K., Leibovici, L., Carmeli, Y. & Paul, M. Systematic review of antibiotic consumption in acute care hospitals. Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis. 22(561), e7-561.e19 (2016).

    Google Scholar 

  16. Beumier, M. et al. Elevated β-lactam concentrations associated with neurological deterioration in ICU septic patients. Minerva Anestesiol. 81, 497–506 (2015).

    Google Scholar 

  17. Fugate, J. E. et al. Cefepime neurotoxicity in the intensive care unit: a cause of severe, underappreciated encephalopathy. Crit. Care Lond. Engl. 17, R264 (2013).

    Google Scholar 

  18. Evans, L. et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 47, 1181–1247 (2021).

    Google Scholar 

  19. Guilhaumou, R. et al. Optimization of the treatment with beta-lactam antibiotics in critically ill patients-guidelines from the French Society of Pharmacology and Therapeutics (Société Française de Pharmacologie et Thérapeutique-SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Société Française d’Anesthésie et Réanimation-SFAR). Crit. Care Lond. Engl. 23, 104 (2019).

    Google Scholar 

  20. Roberts, J. A. et al. DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients?. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 58, 1072–1083 (2014).

    Google Scholar 

  21. Vincent, J. L. et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 22, 707–710 (1996).

  22. Sessler, C. N. et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am. J. Respir. Crit. Care Med. 166, 1338–1344 (2002).

    Google Scholar 

  23. Chanques, G. et al. The CAM-ICU has now a French ‘official’ version. The translation process of the 2014 updated Complete Training Manual of the Confusion Assessment Method for the Intensive Care Unit in French (CAM-ICU.fr). Anaesth. Crit. Care Pain Med. 36, 297–300 (2017).

  24. European Committee on Antimicrobial Susceptibility Testing. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. http://www.eucast.org (2023).

  25. Abdulla, A. et al. The effect of therapeutic drug monitoring of beta-lactam and fluoroquinolones on clinical outcome in critically ill patients: the DOLPHIN trial protocol of a multi-centre randomised controlled trial. BMC Infect. Dis. 20, 57 (2020).

    Google Scholar 

  26. Magréault, S., Jauréguy, F., Carbonnelle, E. & Zahar, J.-R. When and how to use MIC in clinical practice?. Antibiot. Basel Switz. 11, 1748 (2022).

    Google Scholar 

  27. Bellouard, R. et al. Population pharmacokinetic study of cefazolin dosage adaptation in bacteremia and infective endocarditis based on a nomogram. Antimicrob. Agents Chemother. 63, e00806-e819 (2019).

    Google Scholar 

  28. Lalanne, S. et al. Amoxicillin-induced neurotoxicity: contribution of a healthcare data warehouse to the determination of a toxic concentration threshold. Antibiotics 12, 680 (2023).

    Google Scholar 

  29. Jr, D. W. H., Lemeshow, S. & Sturdivant, R. X. Applied Logistic Regression (Wiley, 2013).

  30. Andersen-Ranberg, N. C. et al. Haloperidol for the treatment of delirium in ICU patients. N. Engl. J. Med. 387, 2425–2435 (2022).

    Google Scholar 

  31. Riker, R. R. et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA 301, 489–499 (2009).

    Google Scholar 

  32. Shehabi, Y. et al. Dexmedetomidine and propofol sedation in critically ill patients and dose-associated 90-day mortality: a secondary cohort analysis of a randomized controlled trial (SPICE III). Am. J. Respir. Crit. Care Med. 207, 876–886 (2023).

    Google Scholar 

  33. Barnes, J. et al. Does melatonin administration reduce the incidence of postoperative delirium in adults? Systematic review and meta-analysis. BMJ Open 13, e069950 (2023).

    Google Scholar 

  34. Prakanrattana, U. & Prapaitrakool, S. Efficacy of risperidone for prevention of postoperative delirium in cardiac surgery. Anaesth. Intensive Care 35, 714–719 (2007).

    Google Scholar 

  35. Jung, H. et al. Safety and feasibility of continuous ketamine infusion for analgosedation in medical and cardiac ICU patients who received mechanical ventilation support: A retrospective cohort study. PLoS ONE 17, e0274865 (2022).

    Google Scholar 

  36. Avidan, M. S. et al. Intraoperative ketamine for prevention of postoperative delirium or pain after major surgery in older adults: an international, multicentre, double-blind, randomised clinical trial. Lancet Lond. Engl. 390, 267–275 (2017).

    Google Scholar 

  37. Sonneville, R. et al. Potentially modifiable factors contributing to sepsis-associated encephalopathy. Intensive Care Med. 43, 1075–1084 (2017).

    Google Scholar 

  38. Shiraishi, H., Ito, M., Go, T. & Mikawa, H. High doses of penicillin decreases [3H]flunitrazepam binding sites in rat neuron primary culture. Brain Dev. 15, 356–361 (1993).

    Google Scholar 

  39. Bhattacharyya, S., Darby, R. R., Raibagkar, P., Castro, L. N. G. & Berkowitz, A. L. Antibiotic-associated encephalopathy. Neurology 86, 963–971 (2016).

    Google Scholar 

  40. Payne, L. E. et al. Cefepime-induced neurotoxicity: a systematic review. Crit. Care Lond. Engl. 21, 276 (2017).

    Google Scholar 

  41. Quinton, M.-C. et al. Neurotoxic concentration of piperacillin during continuous infusion in critically ill patients. Antimicrob. Agents Chemother. 61, e00654-e717 (2017).

    Google Scholar 

  42. Grill, M. F. & Maganti, R. K. Neurotoxic effects associated with antibiotic use: management considerations. Br. J. Clin. Pharmacol. 72, 381–393 (2011).

    Google Scholar 

  43. Ewoldt, T. M. J. et al. Model-informed precision dosing of beta-lactam antibiotics and ciprofloxacin in critically ill patients: a multicentre randomised clinical trial. Intensive Care Med. 48, 1760–1771 (2022).

    Google Scholar 

  44. Jean-Michel, V. et al. Continuous infusion of high doses of cefepime in intensive care unit: assessment of steady-state plasma level and incidence on neurotoxicity. Antibiot. Basel Switz. 12, 69 (2022).

    Google Scholar 

  45. Cusumano, J. A. et al. Towards precision medicine: Therapeutic drug monitoring–guided dosing of vancomycin and β-lactam antibiotics to maximize effectiveness and minimize toxicity. Am. J. Health. Syst. Pharm. 77, 1104–1112 (2020).

    Google Scholar 

Download references

Author information

Author notes
  1. These authors contributed equally: Armand Mekontso Dessap and Keyvan Razazi.

  2. A list of authors and their affiliations appears at the end of the paper.

Authors and Affiliations

  1. AP-HP, Hôpitaux Universitaires Henri-Mondor, Service de Médecine Intensive Réanimation, 94010, Créteil, France

    Ségolène Gendreau, Brice Benelli, Guillaume Cintrat, Etienne Dufranc, Romain Arrestier, Pierre Bay, Louise Chantelot, Pascale Labedade, Elsa Moncomble, Guillaume Carteaux, Nicolas de Prost, Armand Mekontso Dessap, Keyvan Razazi, Ségolène Gendreau, Brice Benelli, Guillaume Cintrat, Pascale Labedade, Elsa Moncomble, Pierre Bay, Romain Arrestier, Soraya Mokhtari, Amelie Renou, Darless Clausse, Paul Cirera, Audrey Fogang, Vinoth Anton Raj, Anne-Fleur Haudebourg, Guillaume Rousseau, Anousone Daulasim, Audrey Baron, Lauren Beaudeau, Enora Berti, Flore Biancale, Antoine Bourouchaki, Melissa Ren, Morgan Roue & Rémi Schramm

  2. Université Paris Est Créteil, Faculté de Médecine de Créteil, Institut Mondor de Recherche Biomédicale-Groupe de recherche clinique CARMAS, 94000, Créteil, France

    Ségolène Gendreau, Guillaume Carteaux, Nicolas de Prost, Armand Mekontso Dessap, Keyvan Razazi & Ségolène Gendreau

  3. Université Paris Est Créteil, INSERM, IMRB, 94010, Créteil, France

    Ségolène Gendreau, Guillaume Carteaux, Nicolas de Prost, Anne Hulin, Claire Pressiat, Armand Mekontso Dessap, Keyvan Razazi & Ségolène Gendreau

  4. AP-HP, Hôpitaux Universitaires Henri Mondor, Laboratoire de Pharmacologie, 94010, Créteil, France

    Anne Hulin & Claire Pressiat

Authors
  1. Ségolène Gendreau
    View author publications

    Search author on:PubMed Google Scholar

  2. Brice Benelli
    View author publications

    Search author on:PubMed Google Scholar

  3. Guillaume Cintrat
    View author publications

    Search author on:PubMed Google Scholar

  4. Etienne Dufranc
    View author publications

    Search author on:PubMed Google Scholar

  5. Romain Arrestier
    View author publications

    Search author on:PubMed Google Scholar

  6. Pierre Bay
    View author publications

    Search author on:PubMed Google Scholar

  7. Louise Chantelot
    View author publications

    Search author on:PubMed Google Scholar

  8. Pascale Labedade
    View author publications

    Search author on:PubMed Google Scholar

  9. Elsa Moncomble
    View author publications

    Search author on:PubMed Google Scholar

  10. Guillaume Carteaux
    View author publications

    Search author on:PubMed Google Scholar

  11. Nicolas de Prost
    View author publications

    Search author on:PubMed Google Scholar

  12. Anne Hulin
    View author publications

    Search author on:PubMed Google Scholar

  13. Claire Pressiat
    View author publications

    Search author on:PubMed Google Scholar

  14. Armand Mekontso Dessap
    View author publications

    Search author on:PubMed Google Scholar

  15. Keyvan Razazi
    View author publications

    Search author on:PubMed Google Scholar

Consortia

ADEL study group

  • Ségolène Gendreau
  • , Brice Benelli
  • , Guillaume Cintrat
  • , Pascale Labedade
  • , Elsa Moncomble
  • , Pierre Bay
  • , Romain Arrestier
  • , Soraya Mokhtari
  • , Amelie Renou
  • , Darless Clausse
  • , Paul Cirera
  • , Audrey Fogang
  • , Vinoth Anton Raj
  • , Anne-Fleur Haudebourg
  • , Guillaume Rousseau
  • , Anousone Daulasim
  • , Audrey Baron
  • , Lauren Beaudeau
  • , Enora Berti
  • , Flore Biancale
  • , Antoine Bourouchaki
  • , Melissa Ren
  • , Morgan Roue
  •  & Rémi Schramm

Contributions

Dr S.G., Dr K.R. had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Dr S.G., Dr B.B., Dr G.C., Pr G.C., Pr N.deP., Dr A.H., Dr C.P., Dr K.R., and Dr M.D. contributed to initial study design, analysis, and interpretation of data. Dr R.A., Dr P.B., Dr L.C., Dr P.L., Dr E.M., Dr S.G., Dr B.B., Dr G.C., and the ADEL study group participated to data extraction and analysis. Dr S.G., Dr B.B., Dr G.C., Dr K.R. contributed to drafting of the submitted article. Dr S.G., Dr B.B., Dr G.C., Dr K.R., Dr E.D., Dr R.A., Dr P.B., Dr L.C., Dr P.L., Dr E.M., Pr G.C., Pr N.deP., Dr A.H., Dr C.P., and Dr A.M.D. contributed to critical revisions for intellectual content, and providing final approval of the version to be published.

Corresponding author

Correspondence to Ségolène Gendreau.

Ethics declarations

Ethics approval and consent to participate

This observational prospective study was approved by the Institutional Review Board of the French intensive care medicine society (CE SRLF 17-48) and written and oral information about the study was given to the patients. The data were anonymously collected from medical files in a secure database declared to the National Commission for Information Technology and Civil Liberties.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Supplementary Information.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gendreau, S., Benelli, B., Cintrat, G. et al. Encephalopathy in mechanically ventilated adult patients in the intensive care unit: the role of β-Lactam overdosing. Sci Rep (2026). https://doi.org/10.1038/s41598-026-38709-y

Download citation

  • Received: 01 August 2024

  • Accepted: 30 January 2026

  • Published: 24 February 2026

  • DOI: https://doi.org/10.1038/s41598-026-38709-y

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • Delirium
  • Coma
  • Antibiotics
  • Therapeutic drug monitoring
  • Encephalopathy
  • Neurotoxicity
Download PDF

Advertisement

Explore content

  • Research articles
  • News & Comment
  • Collections
  • Subjects
  • Follow us on Facebook
  • Follow us on X
  • Sign up for alerts
  • RSS feed

About the journal

  • About Scientific Reports
  • Contact
  • Journal policies
  • Guide to referees
  • Calls for Papers
  • Editor's Choice
  • Journal highlights
  • Open Access Fees and Funding

Publish with us

  • For authors
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Scientific Reports (Sci Rep)

ISSN 2045-2322 (online)

nature.com sitemap

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2026 Springer Nature Limited

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing